Increase driven by the fair-value recognition of 9BIT tokens received under the Company's cooperation agreement with the 9BIT Foundation as the9bit continued to expand AI capabilities, community engagement and
Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform that integrates the wisdom of traditional
NYB Partnered with Nvidia, HP and Equinix to Build the World's Largest Natural Compound Library for AI Drug Discovery
SINGAPORE, Oct. 2, 2025 /PRNewswire/ -- The9 Limited (NASDAQ:NCTY) today announced that its
SINGAPORE, Sept. 17, 2024 (GLOBE NEWSWIRE) -- RF Acquisition Corp. ("RFAC" or the "Company") today announced that, in connection with the upcoming special meeting of stockholders scheduled to be held September 23,
GRAND CAYMAN, Cayman Islands, July 01, 2024 (GLOBE NEWSWIRE) -- RF Acquisition Corp II (NASDAQ:RFAIU) (the "Company") announced that, commencing July 5, 2024, holders of the 11,500,000 units sold in the Company's
GRAND CAYMAN, Cayman Islands, May 21, 2024 (GLOBE NEWSWIRE) -- RF Acquisition Corp II (the "Company") today announced that it has closed its initial public offering of 10,000,000 units, at a price of $10.00 per unit.